Selimetry Trials

May 26th, 2017

A trial looking at selumetinib for thyroid cancer that has stopped taking up radioactive iodine (SEL-I-METRY).

The Selimetry trial is now open at the Royal Marsden and more centres will be open soon.

Read more here.

Leave a Reply

Your email address will not be published. Required fields are marked *

We are available on this number on Tuesdays and Fridays from 10 am to 4 pm. Outside these times, please leave a message on our answer phone and we will get back to you as soon as we can.